HCA Healthcare Inc. (NYSE:HCA)

A consistent upward trajectory is observed in both total assets and adjusted total assets from 2017 through 2021, indicating a period of sustained balance sheet expansion.

Total Asset Growth

Total assets increased from US$ 36,593 million in 2017 to US$ 50,742 million in 2021, representing a total growth of approximately 38.6%. The most significant expansion occurred between 2018 and 2019, with an increase of US$ 5,851 million during that interval.

Adjusted Total Asset Trends

Adjusted total assets followed a similar growth pattern, rising from US$ 37,808 million in 2017 to US$ 50,347 million in 2021. This represents a cumulative increase of approximately 33.2% over the five-year period.

Analysis of Asset Adjustments

A shift in the relationship between reported total assets and adjusted total assets occurred during the analyzed period. In 2017 and 2018, adjusted assets were higher than reported total assets, with positive variances of US$ 1,215 million and US$ 1,230 million, respectively. However, starting in 2019, the adjustment became negative, with adjusted total assets falling below reported totals. This negative variance increased from US$ 300 million in 2019 to US$ 395 million by 2021.

An analysis of the liability profile from 2017 to 2021 indicates a general upward trajectory in both total and adjusted total liabilities, characterized by a period of initial adjustment followed by a convergence of metrics.

Liability Growth and Volatility

Total liabilities exhibited a net increase over the five-year period, rising from 41,588 million US$ in 2017 to 49,253 million US$ in 2021. While the growth was consistent between 2017 and 2019, a contraction occurred in 2020, with liabilities decreasing to 44,598 million US$. This was followed by a significant surge in 2021, marking the largest single-year increase in the observed period.

Adjusted Liability Variance

During the 2017 and 2018 fiscal years, a positive variance was observed between total liabilities and adjusted total liabilities. In 2017, the adjusted total liabilities were 1,725 million US$ higher than the reported total. In 2018, this adjustment remained similar, with the adjusted figure exceeding total liabilities by 1,708 million US$.

Metric Convergence

A shift in reporting or valuation occurred starting in 2019, as the adjusted total liabilities converged exactly with the total liabilities. This parity remained constant through 2020 and 2021, suggesting that the specific adjustments applied in the preceding two years were no longer required or were integrated into the primary liability figures.

The financial data reveals a period of significant volatility and recovery in stockholders' equity between 2017 and 2021. A consistent upward trend was observed from 2017 through 2020, during which equity deficits were steadily reduced and eventually transitioned into positive territory. However, this trajectory reversed in 2021, resulting in a contraction of equity values across both reported metrics.

Equity Deficit Recovery (2017-2020)

Stockholders' equity attributable to the company improved from a deficit of 6,806 million USD in 2017 to a positive balance of 572 million USD by December 31, 2020. This indicates a substantial multi-year recovery in the core equity position.

Adjusted Equity Trajectory

The adjusted total stockholders' equity followed a parallel recovery path, moving from a deficit of 5,505 million USD in 2017 to a peak of 2,507 million USD in 2020. While the attributable equity returned to a deficit of 933 million USD in 2021, the adjusted equity remained positive at 1,094 million USD, despite a notable year-over-year decline.

Variance Between Attributable and Adjusted Equity

A consistent positive variance is observed between the adjusted total stockholders' equity and the equity attributable to the company. This gap widened progressively from 1,301 million USD in 2017 to 2,027 million USD in 2021, suggesting that the adjustments applied to the equity position grew in magnitude over the five-year period.

An analysis of the capitalization structure from 2017 to 2021 reveals a consistent trend of balance sheet expansion and a gradual improvement in equity positions, although significant leverage remains a primary characteristic of the financial profile.

Debt Obligations and Adjustments

Total reported debt exhibited relative stability between 2017 and 2020, fluctuating between 31,004 million and 33,722 million US dollars, before increasing to a five-year peak of 34,579 million US dollars in 2021. A consistent variance is observed between reported and adjusted debt figures, with adjusted total debt remaining higher throughout the period. This gap peaked in 2021 at 36,726 million US dollars, indicating a persistent inclusion of additional liabilities in the adjusted calculations.

Equity Position and Deficit Recovery

The stockholders' equity attributable to the company began in a significant deficit of 6,806 million US dollars in 2017. While reported equity reached a brief positive threshold of 572 million US dollars in 2020 before returning to a deficit of 933 million US dollars in 2021, the adjusted equity figures present a more positive trajectory. Adjusted total stockholders' equity improved from a deficit of 5,505 million US dollars in 2017 to a peak of 2,507 million US dollars in 2020, ending the period at 1,094 million US dollars. This suggests that adjustments to the capitalization table significantly mitigate the reported equity deficits.

Total Capital Trends

Both reported and adjusted total capital demonstrate a steady upward trend over the five-year horizon. Total reported capital grew from 26,252 million US dollars in 2017 to 33,646 million US dollars in 2021. Similarly, adjusted total capital increased from 29,278 million US dollars to 37,820 million US dollars over the same period. The consistent growth in total capital, paired with the recovery in adjusted equity, indicates an overall expansion of the company's financial base despite the volatility in reported equity levels.

An upward trajectory in both reported and adjusted net income is evident between 2017 and 2021, characterized by a particularly pronounced acceleration in the final year of the period. While reported net income exhibited moderate volatility between 2018 and 2020, the overall trend remains positive, culminating in a substantial increase in 2021.

Net Income Growth Patterns

Reported net income attributable to HCA Healthcare, Inc. grew from 2,216 million US$ in 2017 to 6,956 million US$ in 2021. The most significant expansion occurred between 2020 and 2021, where income increased by approximately 85%, suggesting a period of high operational performance or significant cost optimization.

Adjusted Net Income Trends

Adjusted net income followed a parallel growth path, rising from 3,235 million US$ in 2017 to 7,836 million US$ in 2021. This metric showed greater stability than reported net income during the 2018 to 2020 interval, which suggests that the adjustments served to normalize earnings by removing volatile or non-recurring elements.

Analysis of Financial Adjustments

A consistent positive variance is observed between adjusted net income and reported net income throughout the entire period. This gap indicates that the company routinely adds back specific expenses or excludes non-recurring losses to arrive at a normalized profitability figure. The absolute difference between the two metrics remained substantial, ranging from a high of 1,019 million US$ in 2017 to 880 million US$ in 2021, reflecting a persistent reliance on adjusted figures to communicate core earnings performance.